Br J Psychiatry. 1981 Oct;139:284-7.

Lithium continuation therapy following electroconvulsive therapy.

Coppen A, Abou-Saleh MT, Milln P, Bailey J, Metcalfe M, Burns BH, Armond A.

Abstract

Thirty-eight depressed patients who were treated with ECT were randomly assigned to receive lithium therapy or identical-looking placebo tablets for one year after clinical recovery in a double-blind trial. The patients who received placebo tablets spent an average of 7.8 weeks with an episode of depression (either as in-patients or day-patients) during the year. In comparison, patients who received lithium spent on average 1.7 weeks with an episode (P less than 0.02). The trial confirms the high rate of relapses after ECT and suggests that lithium considerably reduces this morbidity. It is suggested that ECT without continuation therapy is not a satisfactory treatment of depressive illness.

PMID:: 6799032; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. [JAMA. 2001]
Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, Greenberg RM, Crowe RR, Cooper TB, Prudic J. JAMA. 2001 Mar 14; 285(10):1299-307.
A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. [Acta Psychiatr Scand. 1989]
A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders.
Dinan TG, Barry S. Acta Psychiatr Scand. 1989 Jul; 80(1):97-100.
Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. [Am J Psychiatry. 2000]
Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.
Bauer M, Bschor T, Kunz D, Berghöfer A, Ströhle A, Müller-Oerlinghausen B. Am J Psychiatry. 2000 Sep; 157(9):1429-35.
Review [Antipsychotics in bipolar disorders]. [Encephale. 2004]
Review [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L. Encephale. 2004 Sep-Oct; 30(5):417-24.
Review Treatment of depression in bipolar disorder: new directions for research. [J Clin Psychopharmacol. 1993]
Review Treatment of depression in bipolar disorder: new directions for research.
Zornberg GL, Pope HG Jr. J Clin Psychopharmacol. 1993 Dec; 13(6):397-408.

See reviews... See all...

Cited by 2 PubMed Central articles

Biological classification of depressive illness. [Br J Clin Pharmacol. 1983]
Biological classification of depressive illness.
Coppen A, Wood K. Br J Clin Pharmacol. 1983; 15 Suppl 2:161S-164S.
Review Lithium in the prophylaxis of unipolar depression: a review. [J R Soc Med. 1983]
Review Lithium in the prophylaxis of unipolar depression: a review.
Coppen A, Abou-Saleh MT. J R Soc Med. 1983 Apr; 76(4):297-301.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound
PubChem chemical compound records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records. Multiple substance records may contribute to the PubChem compound record.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Lithium continuation therapy following electroconvulsive therapy.
Lithium continuation therapy following electroconvulsive therapy.
Br J Psychiatry. 1981 Oct ;139:284-7.

PubMed
Specificity of mammalian spermidine synthase and spermine synthase.
Specificity of mammalian spermidine synthase and spermine synthase.
Biochem J. 1981 Aug 1 ;197(2):315-20.

PubMed
The epidemiology of influenza.
The epidemiology of influenza.
Hosp Pract. 1976 Oct ;11(10):49-56.

PubMed
Reinstatement of cocaine-reinforced responding in the rat.
Reinstatement of cocaine-reinforced responding in the rat.
Psychopharmacology (Berl). 1981 ;75(2):134-43.

PubMed
Memory factors in vowel discrimination of normal and at-risk infants.
Memory factors in vowel discrimination of normal and at-risk infants.
Child Dev. 1978 Jun ;49(2):332-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: